Lipo-C (Methionine/Inositol/Choline + B12) — Lipo-C (B12 & Amino Mix) 1650 mg

Lipo-C (Methionine/Inositol/Choline + B12) is a high-purity, multi-component formulation designed for advanced laboratory research into metabolic pathways and cellular energetics. This research tool combines three lipotropic agents—Methionine, Inositol, and Choline—with Vitamin B12 (typically as cyanocobalamin or methylcobalamin) to provide a synergistic system for investigating lipid metabolism. Each component has a distinct and well-characterized biochemical role, and their combination allows for the study of complex interactions within cellular metabolic networks. Methionine is an essential sulfur-containing amino acid (C5H11NO2S) that serves as a crucial precursor for S-adenosylmethionine (SAMe), a universal methyl donor involved in over 100 biochemical reactions, including the synthesis of carnitine, which is essential for fatty acid transport.

Inositol (C6H12O6), a carbocyclic sugar, is a fundamental structural component of eukaryotic cell membranes in the form of phosphatidylinositol. It also acts as a second messenger precursor in critical signal transduction pathways, such as the PI3K/Akt pathway, which governs cellular growth, proliferation, and glucose metabolism. Choline, an essential nutrient, is a precursor to the neurotransmitter acetylcholine and the membrane phospholipid phosphatidylcholine. Its role in synthesizing and exporting very-low-density lipoproteins (VLDL) from the liver makes it a key molecule of interest in studies of hepatic lipid homeostasis. The inclusion of Vitamin B12, a complex organometallic compound, provides a critical cofactor for enzymes like methionine synthase, directly linking it to the methionine cycle and folate metabolism, as well as fatty acid oxidation.

This formulation is of significant interest to researchers investigating the cellular and molecular mechanisms underlying metabolic disorders, particularly non-alcoholic fatty liver disease (NAFLD) and insulin resistance. By providing these key metabolic substrates and cofactors in a single, quality-controlled solution, Nexa Peptides enables researchers to conduct precise and reproducible experiments in cell culture systems and preclinical animal models. The Lipo-C formulation serves as a valuable reagent for elucidating the intricate regulation of lipid transport, methyl group donation, and signal transduction cascades that maintain metabolic homeostasis. All research conducted with this product is intended for laboratory investigation only and is not for human or veterinary use.

The mechanism of action of the Lipo-C formulation is multifaceted, reflecting the distinct yet interconnected biochemical roles of its four components. The primary focus of this combination in a research context is the modulation of lipid metabolism, particularly within hepatocytes, through synergistic effects on methylation, signal transduction, and lipoprotein assembly.

Methionine's primary role is within the methionine cycle, where it is converted to S-adenosylmethionine (SAMe). SAMe is the principal methyl group donor in the cell, participating in the methylation of DNA, proteins, and lipids, thereby regulating gene expression and enzyme function. Critically for lipid metabolism, SAMe is required for the synthesis of phosphatidylcholine (PC) via the phosphatidylethanolamine N-methyltransferase (PEMT) pathway. Furthermore, methionine contributes to the synthesis of glutathione, a primary cellular antioxidant, and carnitine, which is indispensable for the transport of long-chain fatty acids into the mitochondria for β-oxidation. Deficiencies in this pathway are studied in models of hepatic steatosis.

Choline exerts its lipotropic effect primarily through its role as a precursor for PC synthesis via the CDP-choline pathway. PC is an obligatory component of very-low-density lipoprotein (VLDL) particles. In preclinical models, an adequate supply of choline is essential for the assembly and secretion of VLDL from the liver, a process that exports triglycerides and prevents their intracellular accumulation. By providing an exogenous source of choline, researchers can investigate the direct impact on VLDL secretion rates and the subsequent amelioration of hepatic lipid accumulation in cellular and animal models of NAFLD.

Inositol's mechanism is centered on its function as a precursor to phosphoinositides, key signaling molecules. Phosphatidylinositol (4,5)-bisphosphate (PIP2) is hydrolyzed to generate the second messengers inositol trisphosphate (IP3) and diacylglycerol (DAG), which regulate intracellular calcium levels and activate Protein Kinase C (PKC), respectively. Moreover, PIP2 is a substrate for phosphoinositide 3-kinase (PI3K), forming phosphatidylinositol (3,4,5)-trisphosphate (PIP3), a critical docking site for proteins in the insulin signaling pathway, including Akt (Protein Kinase B). By modulating the availability of inositol, researchers can study perturbations in the PI3K/Akt/mTOR pathway, which has profound implications for glucose uptake, glycogen synthesis, and cell survival.

Vitamin B12 functions as an essential cofactor for two enzymes central to this metabolic network. Methionine synthase utilizes methylcobalamin to catalyze the remethylation of homocysteine to methionine, directly replenishing the methionine pool and linking one-carbon metabolism with the folate cycle. The second enzyme, L-methylmalonyl-CoA mutase, requires adenosylcobalamin to convert L-methylmalonyl-CoA to succinyl-CoA, a key intermediate in the Krebs cycle. This reaction is vital for the catabolism of odd-chain fatty acids and certain amino acids. In a research setting, B12 ensures these pathways are not rate-limiting, allowing for a clearer investigation of the effects of the lipotropic agents themselves.

The Lipo-C (Methionine/Inositol/Choline + B12) formulation is a specialized tool utilized in a range of preclinical research applications, primarily centered on cellular and systemic metabolism. Its principal application is in the study of metabolic syndrome and its hepatic manifestation, non-alcoholic fatty liver disease (NAFLD). In both *in vitro* models using hepatocyte cell lines (e.g., HepG2) and *in vivo* rodent models fed high-fat or methionine-choline deficient (MCD) diets, this formulation is used to investigate the mechanisms of hepatic steatosis. Researchers study its potential to enhance the export of triglycerides from the liver by promoting VLDL synthesis and secretion, thereby reducing intracellular lipid droplet accumulation. These studies often involve quantitative lipidomics, gene expression analysis of lipogenic and lipolytic enzymes, and histological examination of liver tissue.

Another significant area of investigation is cellular energy homeostasis. The components of Lipo-C are integral to mitochondrial function. Methionine's role in carnitine synthesis and B12's involvement in the Krebs cycle are directly linked to fatty acid oxidation and ATP production. Researchers utilize this compound in studies designed to assess mitochondrial respiration rates, measure β-oxidation flux, and analyze the expression of key metabolic regulators like peroxisome proliferator-activated receptor alpha (PPARα) and AMP-activated protein kinase (AMPK). These experiments help elucidate how nutrient availability influences cellular bioenergetics and mitochondrial efficiency.

In the field of signal transduction, the inositol component makes this formulation valuable for studying pathways dependent on phosphoinositides. In cell culture experiments, researchers can modulate extracellular inositol levels to examine the downstream consequences on the PI3K/Akt/mTOR pathway. This has applications in research on insulin resistance, where impaired PI3K/Akt signaling is a key pathological feature, as well as in oncology research, where this pathway is often dysregulated. Assays may include Western blotting for phosphorylated Akt and S6 kinase, glucose uptake assays, and cell proliferation studies.

Furthermore, due to choline's role as a precursor to acetylcholine, the Lipo-C formulation is occasionally used in neuroscience research. Studies in this domain may investigate the effects of choline supplementation on acetylcholine synthesis, synaptic plasticity, and cognitive performance in animal models of neurological decline. These investigations often employ techniques such as microdialysis to measure neurotransmitter levels in specific brain regions or behavioral tests to assess memory and learning. In all applications, the Lipo-C formulation is strictly intended for laboratory research purposes to explore fundamental biochemical and physiological processes, not for any form of therapeutic or human use.